ArticleFrontiers in artificial intelligence2020
PECLIDES Neuro: A Personalisable Clinical Decision Support System for Neurological Diseases.
Article in Frontiers in artificial intelligence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Discovering Themes in Deep Brain Stimulation Research Using Explainable Artificial Intelligence.Biomedicines · 2023Review
- Artificial Intelligence You Can Trust: What Matters Beyond Performance When Applying Artificial Intelligence to Renal Histopathology?Journal of the American Society of Nephrology : JASN · 2022Review
- Graph Representation Forecasting of Patient's Medical Conditions: Toward a Digital Twin.Frontiers in genetics · 2021Article
- PECLIDES Neuro: A Personalisable Clinical Decision Support System for Neurological Diseases.Frontiers in artificial intelligence · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodegenerative diseases such as Alzheimer's and Parkinson's impact millions of people worldwide. Early diagnosis has proven to greatly increase the chances of slowing down the diseases' progression. Correct diagnosis often relies on the analysis of large amounts of patient data, and thus lends itself well to support from machine learning algorithms, which are able to learn from past diagnosis and see clearly through the complex interactions of a patient's symptoms and data. Unfortunately, many contemporary machine learning techniques fail to reveal details about how they reach their conclusions, a property considered fundamental when providing a diagnosis. Here we introduce our Personalisable Clinical Decision Support System (PECLIDES), an algorithmic process formulated to address this specific fault in diagnosis detection. PECLIDES provides a clear insight into the decision-making process leading to a diagnosis, making it a gray box model. Our algorithm enriches the fundamental work of Masheyekhi and Gras in data integration, personal medicine, usability, visualization, and interactivity. Our decision support system is an operation of translational medicine. It is based on random forests, is personalisable and allows a clear insight into the decision-making process. A well-structured rule set is created and every rule of the decision-making process can be observed by the user (physician). Furthermore, the user has an impact on the creation of the final rule set and the algorithm allows the comparison of different diseases as well as regional differences in the same disease. The algorithm is applicable to various decision problems. In this paper we will evaluate it on diagnosing neurological diseases and therefore refer to the algorithm as PECLIDES Neuro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.